Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 376, pseudogene (abbreviated RN7SL376P) is a human **processed pseudogene** related to the 7SL RNA gene family[1][2][6][8]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; most arise from the reverse transcription of RNA copies (processed pseudogenes) or from gene duplication events but accumulate disabling mutations and are not translated into proteins[4][5]. The human genome contains hundreds of 7SL RNA-like sequences; only a few code for functional 7SL RNA, the core RNA component of the signal recognition particle (SRP)[5][7][9]. The majority, including RN7SL376P, are **pseudogenes** and are not believed to have biological activity[1][2][6][8]. While some transcribed pseudogenes elsewhere in the genome have been shown to regulate gene expression (e.g., as microRNA decoys or competitive endogenous RNAs), there is no evidence that RN7SL376P is functional in this manner[4][10]. RN7SL376P is not a receptor, enzyme, transporter, or other typical drug target class, nor does it have a described role in pathology or clinical utility[1][2][6][8]. **Summary**: RN7SL376P is a *pseudogene* with sequence homology to the 7SL RNA gene but lacks a known biological or pathological function—it is not considered a therapeutic target, nor does it have interacting drugs or associated safety considerations[1][2][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 376, pseudogene (RN7SL376P).